Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Seres Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule(1) |
Amount Registered |
Proposed Maximum Offering Price Per Unit(1) |
Maximum Aggregate Offering Price(1) |
Fee Rate |
Amount of Registration Fee | |||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.001 per share |
Other | 14,285,715 | $0.89 | $12,714,286.35 | 0.00015310 | $1,946.56 | ||||||||
| Total Offering Amounts | $12,714,286.35 | $1,946.56 | ||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||
| Total Fee Offsets | — | |||||||||||||||
| Net Fee Due | $1,946.56 | |||||||||||||||
| (1) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) of the Securities Act of 1933, as amended, and based on the average of the high and low price of the registrant’s shares of common stock as reported on The Nasdaq Global Select Market on September 26, 2024. |